Camlin Fine — Q1 FY26 earnings call

Call held 8 Aug 2025

Management summary

Camlin Fine Sciences reported a challenging Q1 FY26 with revenue slightly down to INR423 crores and EBITDA at INR19 crores, impacted by significant one-off costs from annual plant maintenance shutdowns and employee bonuses. Despite these headwinds, the high-growth Blends business continued its strong performance, while the Vanillin segment maintained stable volumes amidst channel stock clearance and evolving tariff dynamics. Management expects a rebound as one-off impacts subside and channel inventories normalize.

Highlights

  • Revenue for Q1 FY26 stood at INR423 crores, a slight decrease from INR437 crores in Q1 FY25.

  • EBITDA was INR19 crores, resulting in an EBITDA margin of 4.5% for the quarter.

  • The quarter was impacted by one-off costs including INR12.5 crores unabsorbed fixed costs due to plant shutdowns, INR7.5 crores for one-time employee bonuses, and INR7-8 crores in margin loss from plant start-up consumption.

  • Gross margins reduced from 48% to 44% primarily due to lower production, with sustainable gross margins expected to be 40-45%.

  • The Blends business demonstrated strong growth across geographies, with Mexico achieving 17%+ EBITDA margins and North America at 10-12%.

  • Vanillin business saw a small dip in revenue (INR5 crores) but maintained stable volumes, operating at 50% capacity utilization in Q1, now at 60%.

  • Vanillin average realization in Q1 was $12.5, with current US retail prices at $18-19 and European prices at $14-15.

  • Channel stocks in the US and Europe are expected to clear out in the next 3-4 months.

Concerns

  • Uncertainty and volatility of US tariffs on Indian vanillin

Key financials

  1. Revenue ₹423 Cr -3.2%YoY
  2. EBITDA ₹19 Cr
  3. EBITDA Margin 4.5%
  4. Gross Margin 44%

What they filed

Q1 FY27: revenue up 16.2%, net profit down 9.1% against the same quarter last year.

₹ Cr · quarterly
Line itemQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue227 205 273 191 244 +7%219 +7%184 −33%222 +16%
EBITDA14 16 33 5 18 +29%19 +19%6 −82%7 +40%
Net profit-73 -6 16 -11 -4 +95%-13 −117%-6 −137%-12 −9%
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Segment breakdown

  • Blends Business
    35% Overall Gross Margin$50 Mn Mexico Revenue (FY26)17% Mexico EBITDA Margin$30 Mn North America Revenue (FY26)10% North America EBITDA Margin$25 Mn Brazil Revenue (FY26)10% Brazil EBITDA Margin$15 Mn CFS Vitafor Revenue (FY26)5% CFS Vitafor EBITDA Margin
  • Vanillin Business
    50% Q1 Capacity Utilization60% Current Capacity Utilization12.5 USD/kg Q1 Average Realization18 USD/kg Current US Retail Price14 USD/kg Current Europe Price7.5 USD/kg Current China Price9.25 USD/kg Production Cost (60% Util)540 tons Q1 Third-Party Sales Volume
  • Straights Business
    40% Hydroquinone Gross Margin20% Catechol Gross Margin

Guidance & targets

Profitability

  • Sustainable Gross Margin Profitability · Ongoing · Medium confidence 40-45%
    It will be in the region of 40% to 45% gross margins in that range, 2% or 3% up or down will be sustainable. So we are at 44%, it could go to 47%, 48%. It's 2% or 3% up or down from where we are.

    — Nirmal Momaya, Managing Director

  • China Business Losses Profitability · End of FY26 · High confidence Zero
    Yes. So China should go away this financial year, by the end of the FY '26, I mean, we should be by the end of the year, China will go away.

    — Nirmal Momaya, Managing Director

Volume

  • Vanillin Annual Sales Volume Volume · Annual · High confidence 2,500-3,000 tons
    All we are saying is that our vanillin business will work at about -- the estimated volumes are at about 2,500 to 3,000 tons.

    — Nirmal Momaya, Managing Director

Realization

  • Vanillin Average Realization Realization · Through the year · Medium confidence $13-14
    Expected realizations would be in the $13 to$14 through the year average for the year.

    — Nirmal Momaya, Managing Director

Growth

  • Blends Business Growth Growth · Ongoing · High confidence 20%
    So 20% Blends business growth is intact, right? Yes.

    — Nirmal Momaya, Managing Director

Capacity

  • Vanillin Capacity Utilization Capacity · FY27 · Medium confidence 70-80%
    So the estimate is that we should be at about 70% to 80% capacity utilization in FY '27.

    — Nirmal Momaya, Managing Director

  • Vanillin Capacity Utilization Capacity · FY28 · Medium confidence Full capacity
    And I think there we'll get a clear idea, but FY '28 is what we are saying we should be at a full capacity utilization.

    — Nirmal Momaya, Managing Director

Inventory

  • Channel Stock Clearance (US & Europe) Inventory · Next 3-4 months · Medium confidence 3-4 months
    But our estimate is that stock also should not the overhang of that should not go more than 3, 4 months.

    — Nirmal Momaya, Managing Director

Cost

  • Europe Site Cost Cost · Next financial year · High confidence INR2 crores/quarter
    Europe, we yet have to maintain the site. So there will be some cost of keeping that mothballed site, which we have said that our estimate is it will be about INR2 crores a quarter in the next financial year.

    — Nirmal Momaya, Managing Director

  • Europe Site Cost Cost · This financial year · High confidence INR5 crores/quarter
    But this financial year, we will have a similar run rate of around INR5 crores per quarter on Europe.

    — Santosh Parab, Chief Financial Officer

Risks & concerns

  • Uncertainty and volatility of US tariffs on Indian vanillin

    high

    Current US tariff is 50% and is a moving target; management notes it's unprecedented and difficult to predict future changes (e.g., could go to 150%).

    Management acknowledged

  • Channel stock overhang in US and Europe for vanillin

    medium

    Observing channel stocks in main geographies (Europe and US) where antidumping duty is present, impacting average realization.

    Management acknowledged

  • Sluggish demand and Chinese competition globally

    medium

    There is sluggish demand and Chinese issues all over the world, with Trump tariffs also being a watch item.

    Management acknowledged

  • Potential for Chinese competitors to enter market if prices are too high

    medium

    If vanillin prices (including tariffs) become too high, it could make it viable for Chinese competitors (with 280% duty) to re-enter the market.

    Management acknowledged

Areas of evasion (2)

  • exact future movement of US tariffs
  • Solvay's production cost

Q&A highlights

2 direct
Breakdown of one-off costs impacting Q1 EBITDA Direct
We had unabsorbed fixed of about INR12.5 crores in all our plants in the month of April and around INR7.5 crores was paid for one-time bonus to the employees of Blends. Apart from this, there was no as I said, we also had 2% to 3% of margin loss because of start-up of plants. We had closed the plants. We started the plants. The first dosing, the consumption increases. That will be around 2% to 3%, that will be another INR7 crores to INR8 crores.

Provides clear quantification of the temporary factors that suppressed Q1 profitability, allowing investors to adjust their view of underlying performance.

Asked by Raman KV

Blends business margins and overall EBITDA discrepancy Partial
So we have been saying that, yes, when the Blends business is mature, it does get a high teen margin. But as you know, there are a couple of geographies, which are very mature, especially Mexico, where we have 17% plus EBITDA margins, in America also, it's around 15%. But there are other geographies like India or Europe and the Vitafor piece, these are growing businesses where the margins are in the range of 8% to 10%. So the overall margins are not 17%, 18%, but sub-12%, 13%.

Clarifies the blended margin profile of the Blends business, explaining why the overall segment margin is lower than the high-teen margins seen in mature markets, which is crucial for accurate valuation.

Asked by Raman KV

Impact of US tariffs on vanillin realization and pricing strategy Direct
No. Whoever is importing our products will have to pay the 50% tariff. And like I explained earlier, our competitors in China are at 280% with the antidumping duty and tariffs on China. We are competitive versus that.

Addresses the critical issue of tariff pass-through and competitive positioning in the US vanillin market, indicating that the company remains competitive despite the 50% tariff due to higher duties on Chinese imports.

Asked by Chaitya Doshi

3 min read 6 chapters

Detailed narrative

Q1 FY26 Performance and One-off Impacts

Camlin Fine Sciences reported a Q1 FY26 revenue of INR423 crores, a slight decline from INR437 crores in the prior year. EBITDA for the quarter was INR19 crores, translating to an EBITDA margin of 4.5%. This performance was significantly impacted by several one-off events: INR12.5 crores in unabsorbed fixed costs due to annual maintenance shutdowns at Dahej and Tarapur facilities in April, INR7.5 crores for one-time performance bonuses to Blends business employees, and an additional INR7-8 crores in margin loss from higher consumption during plant start-ups. These factors collectively suppressed the quarter's profitability.

Blends Business: Strong Growth and Evolving Margins

The Blends business continued its strong growth trajectory across all geographies, with management confirming a 20% growth target remains intact. EBITDA margins vary by maturity: Mexico, a mature market, boasts 17%+ margins, while North America is at 10-12% (expected to reach high-teen next year). Growing regions like India, Europe, and Vitafor (expected $15-16 million revenue this year) currently have margins in the 8-10% range. The overall blended gross margin for this segment is typically 35-40%, with management investing in sales teams to drive future growth.

Vanillin Business: Tariff Challenges and Capacity Utilization

The Vanillin business experienced a small revenue dip of INR5 crores but maintained stable volumes. Capacity utilization in Q1 was around 50% due to plant shutdowns, currently running at 60%. Management aims for 70-80% utilization by FY27 and full capacity by FY28. Average realization in Q1 was $12.5/kg, with current US retail prices at $18-19/kg and European prices at $14-15/kg. The US market faces a 50% tariff on Indian vanillin, but Camlin remains competitive due to significantly higher antidumping duties (280%) on Chinese producers.

Gross Margin Outlook and Segment Profitability

Overall gross margins for the company decreased from 48% to 44% in Q1 FY26, primarily due to lower production volumes. Management expects sustainable gross margins to be in the 40-45% range going forward. Within the Straights business, the hydroquinone chain typically yields gross margins closer to 50%, while the catechol chain is around 20%. The Blends business maintains a gross margin of 35-40%.

Market Strategy and Inventory Clearance

Camlin Fine Sciences is closely monitoring channel stocks in Europe and the US, which are expected to clear within the next 3-4 months. New contracts for vanillin are typically finalized in October-November for January delivery. The company aims for an annual vanillin sales volume of 2,500-3,000 tons, with a target mix of 40% to Europe, 30-40% to the US, and the balance to the rest of the world. Despite tariff uncertainties, the strategy is to maintain a presence in both key geographies to service multinational customers.

China and Europe Business Outlook

Management expects losses from the China business to be eliminated by the end of FY26. For the mothballed Europe site, the cost is estimated to be around INR5 crores per quarter for the current financial year, reducing to approximately INR2 crores per quarter in the next financial year. The company is focusing on high-purity, high-quality vanillin for high value-added F&B products in markets where Chinese players might challenge on price.

This is an AI-generated summary of a publicly available earnings call transcript.
View original transcript

More Chemicals earnings calls